The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pongratz, G.
Right arrow Articles by Sanders, V. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pongratz, G.
Right arrow Articles by Sanders, V. M.
The Journal of Immunology, 2006, 177: 2926-2938.
Copyright © 2006 by The American Association of Immunologists, Inc.

The Level of IgE Produced by a B Cell Is Regulated by Norepinephrine in a p38 MAPK- and CD23-Dependent Manner1

Georg Pongratz*, Jaclyn W. McAlees*, Daniel H. Conrad{dagger}, Robert S. Erbe*, Karen M. Haas{ddagger} and Virginia M. Sanders2,*

* Department of Molecular Virology, Immunology, and Medical Genetics, Ohio State University, Columbus, OH 43210; {dagger} Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA 23298; and {ddagger} Department of Immunology, Duke University Medical Center, Durham, NC 27710

Although the causes of asthma vary, the severity of the disease correlates with the level of IgE produced. In this study we show that mice produced less IgE when they were depleted of the neurotransmitter norepinephrine (NE) before the administration of Ag. The suppression was prevented when a beta2-adrenergic receptor (beta2AR)-selective agonist was administered, suggesting that NE stimulated the beta2AR to regulate the level of an IgE response in vivo. Although the cell targeted by NE to produce this effect in vivo is unknown, we show in vitro that the level of IgE increased on a per cell basis without an effect on class switch recombination when NE stimulated the beta2AR on a B cell directly. The beta2AR-induced increase in IgE depended on p38 MAPK but not protein kinase A activation, was due to an increased rate of mature IgE mRNA transcription, and was lost when beta2AR-deficient B cells were used. Also, CD23 transcription was increased in a p38 MAPK-dependent manner and resulted in an increased level of soluble CD23 (sCD23). The beta2AR-induced increase in sCD23 was associated with IgE up-regulation and possibly interacted with CD21/CD19. Using B cells from respective knockout mice, data showed that the beta2AR-induced increase in IgE depended on B cell expression of CD23, CD21, and CD19. These findings suggest that at least one mechanism by which endogenous B cell activity in vivo is regulated by NE involves stimulation of the beta2AR on the B cell alone to increase the level of IgE produced in a p38 MAPK- and sCD23-dependent manner.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported in part by National Institutes of Health Grants AI37326 and A147420 (to V.M.S.) and Deutsche Forschungsgemeinschaft Grant PO 801/1-1 (to G.P.).

2 Address correspondence and reprint requests to Dr. Virginia Sanders, Department of Molecular Virology, Immunology, and Medical Genetics, Ohio State University, 2194 Graves Hall, 333 West 10th Avenue, Columbus, OH 43210. E-mail address: sanders.302{at}osu.edu

3 Abbreviations used in this paper: BAL, bronchoalveolar lavage; AR, adrenergic receptor; ATF-2, activating transcription factor 2; BALT, bronchus-associated lymphatic tissue; CSR, class switch recombination; GC, germinal center; i.t., intratracheal(ly); mCD23, membrane-bound CD23; NE, norepinephrine; sCD23, soluble CD23; 6-OHDA, 6-hydroxydopamine; PKA, protein kinase.




This article has been cited by other articles:


Home page
J. Immunol.Home page
X. Liu, L. Ye, Y. Bai, H. Mojidi, N. E. Simister, and X. Zhu
Activation of the JAK/STAT-1 Signaling Pathway by IFN-{gamma} Can Down-Regulate Functional Expression of the MHC Class I-Related Neonatal Fc Receptor for IgG
J. Immunol., July 1, 2008; 181(1): 449 - 463.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ganguly, C. Grodzki, D. Sugden, M. Moller, S. Odom, P. Gaildrat, I. Gery, R. P. Siraganian, J. Rivera, and D. C. Klein
Neural Adrenergic/Cyclic AMP Regulation of the Immunoglobulin E Receptor {alpha}-Subunit Expression in the Mammalian Pinealocyte: A NEUROENDOCRINE/IMMUNE RESPONSE LINK?
J. Biol. Chem., November 9, 2007; 282(45): 32758 - 32764.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. W. Kin and V. M. Sanders
CD86 Regulates IgG1 Production via a CD19-Dependent Mechanism
J. Immunol., August 1, 2007; 179(3): 1516 - 1523.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.